This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Is First Trust Dow 30 Equal Weight ETF (EDOW) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EDOW
CVS Stock Hits 50-Day SMA on Split Rumors: How Should You Play?
by Urmimala Biswas
The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
Zacks Investment Ideas feature highlights: Taiwan Semiconductor Manufacturing, UnitedHealth and Lockheed Martin
by Zacks Equity Research
Taiwan Semiconductor Manufacturing, UnitedHealth and Lockheed Martin are part of the Zacks Investment Ideas article.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
by Zacks Equity Research
UnitedHealth Group (UNH) concluded the recent trading session at $584.68, signifying a +0.49% move from its prior day's close.
A Closer Look at Wide Moat Stocks
by Derek Lewis
The essence of the "wide moat" investment theme is when businesses possess durable competitive advantages - dubbed moats - that shield them from competitors.
Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
The Zacks Analyst Blog Highlights American Express, Coca-Cola and UnitedHealth
by Zacks Equity Research
American Express, Coca-Cola and UnitedHealth are part of the Zacks top Analyst Blog.
3 Blue-Chip Stocks to Buy as Dow Maintains Northbound Journey
by Nalak Das
Buy three blue-chip stocks to tap recent Dow rally. These stocks are AXP, KO and UNH.
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?
by Kaibalya Pravo Dey
With expansion into targeted markets and strategic diversification, UNH still has significant growth potential left.
3 Top Large Cap Stocks for a Stable Approach: ETN, DECK, UNH
by Derek Lewis
Large cap stocks carry a well-established nature, have greater analyst coverage, and commonly pay dividends, all of which make them so popular.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EDOW
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $589.14, marking a -0.87% move from the previous day.
Beat the Market Like Zacks: UnitedHealth, Badger Meter, 3M in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
UnitedHealth Group (UNH) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
UnitedHealth Group (UNH) concluded the recent trading session at $594.10, signifying a -0.47% move from its prior day's close.
Why UnitedHealth Group (UNH) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
The Zacks Analyst Blog Highlights UnitedHealth, Procter & Gamble, HSBC and Oil-Dri
by Zacks Equity Research
UnitedHealth, Procter & Gamble, HSBC and Oil-Dri are part of the Zacks Analyst Blog
UnitedHealth Group (UNH) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the most recent trading session, UnitedHealth Group (UNH) closed at $598.68, indicating a +1.44% shift from the previous trading day.
Top Analyst Reports for UnitedHealth, Procter & Gamble & HSBC
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Procter & Gamble Company (PG) and HSBC Holdings plc (HSBC), as well as a micro-cap stock Oil-Dri Corporation of America (ODC).
Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?